PTC CLINIC
Information for Healthcare Professionals

Clinical Studies: Participation in professional studies in the Czech Republic and abroad

1. Participation in the study IESLG 37 (role of consolidation RT in patients with primary mediastinal B-lymphoma). Department of Internal Hematology, University Hospital Královské Vinohrady, Department of Oncology, 2nd Medical Faculty, Charles University and Motol University Hospital (provision of modern photon RT – IMRT, VMAT technology)
2. Dose-Reduced Consolidation Radiation Therapy in Patients With Diffuse Large B-cell Lymphoma. (Phase II of the study).DLBCL International Study – ILROG Paris Research Collaboration – Phase II DLBCL Study conducted by DUKE Cancer Institute, Department of Radiology. Participation together with Motol University Hospital.
3. Impact of DHL/THL on RT efficacy for r/r DLBCL patients. ILROG collaborative study. Účast ve studii ILROG s DHL/THL DLBCL, studii vede University of Washington, Dr. Yolanda Tseng.
4. An Excess Mortality Risk Analysis of Proton Beam versus Optimal Proton Radiotherapy for Mediastinal Hodgkin  Lymphoma: Who May Benefit Most? Model study with Nuffield Dpt. University of Oxford + St. Guy´s Hospital – Ongoing collaboration, analysis of PTC patients.
5. In cooperation with Motol University Hospital, PTC also contributes to the study EuroNet – PHL – C2 led by Prof. Andreas Dieckmann, AKH Wien.
6. Proton Therapy in Supradiaphragmatic Lymphoma: Predicting Treatment-Related Mortality to Help Optimize Patient Selection published on Oct 28, 2021, in the Red Journal.